# Naloxone for Optimizing Hypoxemia Of Lung Donors

> **NCT02581111** · PHASE2,PHASE3 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 199 (actual)

## Conditions studied

- Brain Death
- Organ Donors
- Lung Transplantation

## Interventions

- **DRUG:** Naloxone
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02581111
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-09-22
- **Final completion:** 2017-09-25
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2020-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581111, "Naloxone for Optimizing Hypoxemia Of Lung Donors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02581111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*